financetom
Business
financetom
/
Business
/
Annexon Prices $125 Million Stock Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Annexon Prices $125 Million Stock Offering
Jun 6, 2024 1:12 AM

03:52 AM EDT, 06/06/2024 (MT Newswires) -- Annexon ( ANNX ) said late Wednesday it priced an underwritten public offering of about 13 million common shares at $6.25 per share, and pre-funded warrants to buy 7 million shares at $6.249 per share, for expected gross proceeds of $125 million.

The company granted the underwriters a 30-day option to buy up to an additional about 3 million shares.

The offering is expected to close on Friday.

Price: 6.78, Change: -0.01, Percent Change: -0.15

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
uniQure Stock Doubles On Promising Data From Huntington's Disease Trial
uniQure Stock Doubles On Promising Data From Huntington's Disease Trial
Sep 24, 2025
uniQure N.V. on Wednesday released topline data from the pivotal Phase 1/2 study of AMT-130 for Huntington’s disease. Huntington’s disease is an inherited condition in which nerve cells in the brain break down over time. The disease affects a person’s movements, thinking ability and mental health. The study met its prespecified primary endpoint, with high-dose AMT-130 demonstrating a statistically significant...
Form 8.3 - Spirent Communications plc
Form 8.3 - Spirent Communications plc
Sep 24, 2025
BOSTON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global Opportunity Fund) (b) Owner or controller of interests...
Form 8.3 - Mural Oncology plc
Form 8.3 - Mural Oncology plc
Sep 24, 2025
LONDON--(BUSINESS WIRE)--   Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if...
Form 8.3 - Dalata Hotel Group plc
Form 8.3 - Dalata Hotel Group plc
Sep 24, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different...
Copyright 2023-2026 - www.financetom.com All Rights Reserved